Functioning of patients at the early stage of schizophrenia

Functioning of patients at the early stage of schizophrenia

 

Authors

 

N.N. Petrova

Federal State Budgetary Educational Institution of Higher Education “Saint Petersburg State University”, Saint Petersburg, Russian Federation

V.M. Manyushina

Federal State Budgetary Educational Institution of Higher Education “Saint Petersburg State University”, Saint Petersburg, Russian Federation

 

https://doi.org/10.26617/1810-3111-2025-3(128)-37-48

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2025; 3 (128):  37-48.

 

Abstract

Background. Functional recovery of patients with schizophrenia (psychopharmacotherapy, psychotherapy, and social rehabilitation) is a pressing goal of modern psychiatry. Identification of factors influencing patient functioning can improve the prognosis of the functional outcome of the disease using a scale for assessing the functional state and predicting the outcome. Objective: to assess the functioning of patients at an early stage of schizophrenia and to identify factors influencing the functional outcome. The study was conducted at the clinical site of the Department of Psychiatry and Narcology of the Medical Institute of St. Petersburg State University. Materials and Methods. Patients (n=160) with paranoid schizophrenia (F20.0) in remission were examined. The total sample was divided into two groups: the main group consisted of patients (n=160) with the first episode (up to 5 years of disease progression, no more than 3 attacks), and the comparison group consisted of patients (n=80) with the disease duration of more than 5 years. Patients’ functioning (study/work, family, education, health, availability of support from relatives and social services) was assessed using the Personal and Social Performance Scale (PSP) and the Global Assessment of Functioning (GAF). Results. Patients at the early stage of schizophrenia had a statistically significantly (p<0.05) higher level of social functioning compared to long-term ill patients (70.5±10.81 and 50.67±6.90 points on the PSP; 82.5±9.71 and 63.81±7.90 points on the GAF). Statistically significant (p<0.05) differences in social functioning were found between patients in the compared groups with different disease durations (4.6±0.85 points and 2.6±0.96 points on the PSP scale). In the main and comparison groups, statistically significantly (p<0.05) higher total PSP scores were found in female patients compared to male patients (in patients with the first psychotic episode ‒ 76.1±9.79 and 61.21±6.75 points, in long-term patients ‒ 53.68±7.94 and 49.85±6.54 points). The level of functioning at the early stage of schizophrenia was higher in patients who did not have a disability due to mental illness, who received higher education, and were employed. Results of multiple linear regression demonstrated that a favorable functional outcome with preservation/restoration of the level of social functioning was influenced by the later age of disease onset (β=-0.86, p<0.01), the female sex (β=3.25, p<0.05), the absence of neurological side effects of therapy (β=-0.84, p<0.05), living with their own family (β=3.11, p<0.05), having higher education (β=8.91, p<0.001), maintaining employment status (β=1.29, p<0.05), the absence of disability (β=5.71, p<0.01), lesser severity of cognitive impairment (β=-0.295, p=0.01) and negative symptoms (β=-1.869, p<0.001). Conclusions. Female patients have been shown to have higher levels of personal and social functioning than males, regardless of the disease stage. The most significant differences between patients in the early and chronic stages of the disease concern the domain of socially useful activity. The functional outcome of schizophrenia is the result of the influence of diverse factors, requiring the integration of psychopharmacological and psychosocial approaches.

 

Keywords: paranoid schizophrenia, prodromal, manifest, residual stages of schizophrenia, personal and social functioning, factors and resources of functioning, sex.

 

Article (pdf)

 

Contacts

 

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

For citation: Petrova N.N., Manyushina V.M. Functioning of patients at the early stage of schizophrenia. Siberian Herald of Psychiatry and Addiction Psychiatry.2025; 3 (128): 37-48. https://doi.org/10.26617/1810-3111-2025-3(128)-37-48

 

REFERENCES

  1. Gurovich IYa, Storozhakova YaA, Shmukler AB. Psychosocial treatment and rehabilitation direction in psychiatry. Social and Clinical Psychiatry. 2004;14(1):81-86 (in Russian).
  2. Agarwal SM, Dissanayake J, Agid O, Bowie C, Brierley N, Chintoh A, De Luca V, Diaconescu A, Gerretsen P, Graff-Guerrero A, Hawco C, Herman Y, Hill S, Hum K, Husain MO, Kennedy JL, Kiang M, Kidd S, Kozloff N, Maslej M, Mueller DJ, Naeem F, Neufeld N, Remington G, Rotenberg M, Selby P, Siddiqui I, Szacun-Shimizu K, Tiwari AK, Thirunavukkarasu S, Wang W, Yu J, Zai CC, Zipursky R, Hahn M, Foussias G. Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol. PLoS One. 2023 Sep 21;18(9):e0288354. https://doi.org/10.1371/journal.pone.0288354. PMID: 37733693; PMCID: PMC10513234.
  3. Wójciak P, Domowicz K, Andrzejewska M, Rybakowski JK. Negative symptoms in schizophrenia, assessed by the brief negative symptom scale, self-evaluation of negative symptom scale, and social cognition: a gender effect. Int J Psychiatry Clin Pract. 2021 Sep;25(3):252-257. https://doi.org/10.1080/13651501.2020.1810278. Epub 2020 Aug 31. PMID: 32862741.
  4. Keefe RSE. Why are there no approved treatments for cognitive impairment in schizophrenia? World Psychiatry. 2019 Jun;18(2):167-168. https://doi.org/10.1002/wps.20648. PMID: 31059617; PMCID: PMC6502426.
  5. Giordano GM, Bucci P, Mucci A, Pezzella P, Galderisi S. Gender differences in clinical and psychosocial features among persons with schizophrenia: A mini review. Front Psychiatry. 2021 Dec 22;12:789179. https://doi.org/10.3389/fpsyt.2021.789179. PMID: 35002807; PMCID: PMC8727372.
  6. Goodsmith N, Cohen AN, Pedersen ER, Evans E, Young AS, Hamilton AB. Predictors of functioning and recovery among men and women veterans with schizophrenia. Community Ment Health J. 2023 Jan;59(1):110-121. https://doi.org/10.1007/s10597-022-00979-x. Epub 2022 May 28. PMID: 35643881.
  7. Escandell MJ, Prat G, Garcia-Franco M, Martín-Martínez JR, Ochoa S, Tortades I, Vilamala S, Verdaguer-Rodríguez M, Casas-Anguera E. Clinical symptoms and social functioning in schizophrenia. Rev Psiquiatr Salud Ment (Engl Ed). 2022 Oct-Dec;15(4):251-258. https://doi.org/10.1016/j.rpsmen.2020.05.003. PMID: 36513401.
  8. Prat G, Escandell MJ, Garcia-Franco M, Martín-Martínez JR, Tortades I, Vilamala S, Calderón M, Torras R, Ochoa S, Casas-Anguera E. Gender differences in social functioning in people with schizophrenia in psychosocial rehabilitation services using one-dimensional and multidimensional instruments. Compr Psychiatry. 2018 Nov;87:120-122. https://doi.org/10.1016/j.comppsych.2018.10.004. Epub 2018 Oct 13. PMID: 30340017.
  9. Golubev SA, Lezheĭko TV, Korovaitseva GI, Gabaeva MV, Kolesina NYu, Kaleda VG, Golimbet VE. Prognosis of the functional outcome of schizophrenia using a multigene panel. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(7):70‑76. https://doi.org/10.17116/jnevro202112107170(in Russian).
  10. Jääskeläinen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, Veijola J, Miettunen J. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013 Nov;39(6):1296-306. https://doi.org/10.1093/schbul/sbs130. Epub 2012 Nov 20. PMID: 23172003; PMCID: PMC3796077.
  11. Agarwal SM, Dissanayake J, Agid O, Bowie C, Brierley N, Chintoh A, De Luca V, Diaconescu A, Gerretsen P, Graff-Guerrero A, Hawco C, Herman Y, Hill S, Hum K, Husain MO, Kennedy JL, Kiang M, Kidd S, Kozloff N, Maslej M, Mueller DJ, Naeem F, Neufeld N, Remington G, Rotenberg M, Selby P, Siddiqui I, Szacun-Shimizu K, Tiwari AK, Thirunavukkarasu S, Wang W, Yu J, Zai CC, Zipursky R, Hahn M, Foussias G. Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol. PLoS One. 2023 Sep 21;18(9):e0288354. https://doi.org/10.1371/journal.pone.0288354. PMID: 37733693; PMCID: PMC10513234.
  12. Chong HY, Teoh SL, Wu DB, Kotirum S, Chiou CF, Chaiyakunapruk N. Global economic burden of schizophrenia: a systematic review. Neuropsychiatr Dis Treat. 2016 Feb 16;12:357-73. https://doi.org/10.2147/NDT.S96649. PMID: 26937191; PMCID: PMC4762470.
  13. Lewine R, Hart M. Schizophrenia spectrum and other psychotic disorders. Handb Clin Neurol. 2020;175:315-333. https://doi.org/10.1016/B978-0-444-64123-6.00022-9. PMID: 33008535.
  14. Московская Н.Л., Куницына Е.В. К вопросу о соотношении понятий пол и гендер. Актуальные проблемы гуманитарных и естественных наук. 2011. № 5. С. 105-107. MoskovskayaNL, KunitsynaEV. On the relationship between the concepts of sex and gender. Actual Problems of Humanitarian and Natural Sciences. 2011;5:105-107 (in Russian).
  15. Zakharov NB, Zlokazova MV, Semakina NV. Gender factor and mental disorders. Vyatka Medical Bulletin. 2022;3(75):77-81. https://doi.org/10.24412/2220-7880-2022-375-77-81 (in Russian).
  16. Chan RCH, Mak WWS, Chio FHN, Tong ACY. Flourishing with psychosis: A prospective examination on the interactions between clinical, functional, and personal recovery processes on well-being among individuals with schizophrenia spectrum disorders. Schizophr Bull. 2018 Jun 6;44(4):778-786. https://doi.org/10.1093/schbul/sbx120. PMID: 28981851; PMCID: PMC6007346.
  17. Bouwmans C, de Sonneville C, Mulder CL, Hakkaart-van Roijen L. Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat. 2015 Aug 18;11:2125-42. https://doi.org/10.2147/NDT.S83546. PMID: 26316759; PMCID: PMC4547637.
  18. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand. 2000 Apr;101(4):323-9. PMID: 10782554
  19. Jones SH, Thornicroft G, Coffey M, Dunn G. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry. 1995 May;166(5):654-9. https://doi.org/10.1192/bjp.166.5.654. PMID: 7620753.
  20. Mosolov SN. Scales of psychometric assessment of schizophrenia symptoms and the concept of positive and negative disorders. Moscow, 2001:238 (in Russian).
  21. Andreasen NC. The Scale for the assessment of negative symptoms (SANS): conceptual and theoretical foundations. Br J Psychiatry Suppl. 1989 Nov;(7):49-58. PMID: 2695141.
  22. Fedotov IA, Pavlichenko AV, Chumakov EM, Leonova AV, Sorokin MYu, Bogoyavlenskaya VYu, Vlasova VA, Kuznetsova AR, Petrova NN. Results of a multicenter clinical study on adaptation and validation of the Russian version of the Clinical Assessment Interview for Negative Symptoms (CAINS). VM Bekhterev Review of Psychiatry and Medical Psychology. 2024;58(4-1):107-119. https://doi.org/10.31363/2313-7053-2024-971 (in Russian).
  23. Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004 Jun 1;68(2-3):283-97. https://doi.org/10.1016/j.schres.2003.09.011. PMID: 15099610.
  24. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1-100. https://doi.org/10.1111/j.1600-0447.1987.tb10566.x.
  25. Petrova NN, Tsyrenova KA. Clinical and therapeutic factors affecting the social adaptation of patients with schizophrenia. Psychiatry (Moscow). 2021;19(4):26-33 https://doi.org/10.30629/2618-6667-2021-19-4-26-33(in Russian).
  26. Marwaha S, Johnson S. Schizophrenia and employment - a review. Soc Psychiatry Psychiatr Epidemiol. 2004 May;39(5):337-49. https://doi.org/10.1007/s00127-004-0762-4. PMID: 15133589.
  27. Petrova NN, Voinkova EE, Dorofeykova MV. Gender characteristics of the first episode of schizophrenia. Mental Health. 2018;5:43-51 (in Russian).
  28. Dubreucq M, Plasse J, Gabayet F, Blanc O, Chereau I, Cervello S, Couhet G, Demily C, Guillard-Bouhet N, Gouache B, Jaafari N, Legrand G, Legros-Lafarge E, Mora G, Pommier R, Quilès C, Verdoux H, Vignaga F, Massoubre C, Franck N, Dubreucq J; REHABase Network. Sex differences in recovery-related outcomes and needs for psychiatric rehabilitation in people with schizophrenia spectrum disorder. J Clin Psychiatry. 2021 May 18;82(4):20m13732. https://doi.org/10.4088/JCP.20m13732. PMID: 34010524.
  29. Bottlender R, Strauss A, Möller HJ. Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission. Schizophr Res. 2010 Jan;116(1):9-15. https://doi.org/10.1016/j.schres.2009.10.008. PMID: 19896334.
  30. Thara R, Kamath S. Women and schizophrenia. Indian J Psychiatry. 2015 Jul;57(Suppl 2):S246-51. https://doi.org/10.4103/0019-5545.161487. PMID: 26330642; PMCID: PMC4539869.
  31. Dama M, Veru F, Schmitz N, Shah J, Iyer S, Joober R, Malla A. Sex differences in clinical and functional outcomes among patients treated in an early intervention service for psychotic disorders: An observational study. Can J Psychiatry. 2019 Oct;64(10):708-717. https//doi.org/10.1177/0706743719854069. Epub 2019 Jun 12. PMID: 31189340; PMCID: PMC6783666.
  32. Fervaha G, Foussias G, Agid O, Remington G. Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome. Schizophr Res. 2015 Aug;166(1-3):9-16. https//doi.org/10.1016/j.schres.2015.04.040. Epub 2015 May 15. PMID: 25982811.
  33. García-Fernández L, Romero-Ferreiro V, Sánchez-Pastor L, Dompablo M, Martínez-Gras I, Espejo-Saavedra JM, Rentero D, Aparicio AI, Alvarez-Mon MA, Lahera G, Lee J, Santos JL, Rodriguez-Jimenez R. Impact of negative symptoms on functioning and quality of life in first psychotic episodes of schizophrenia. J Clin Med. 2022 Feb 14;11(4):983. https//doi.org/10.3390/jcm11040983. PMID: 35207256; PMCID: PMC8879613.
  34. Papsuev OO, Shevchenko VA, Semenchuk LI, Suslov SE. Clinical and social characteristics of disabled patients suffering from schizophrenia and schizophrenia spectrum disorders. Social and Clinical Psychiatry. 2007;17(3):5-9 (in Russian).
  35. Ajnakina O, Stubbs B, Francis E, Gaughran F, David AS, Murray RM, Lally J. Employment and relationship outcomes in first-episode psychosis: A systematic review and meta-analysis of longitudinal studies. Schizophr Res. 2021 May;231:122-133. https//doi.org/10.1016/j.schres.2021.03.013. Epub 2021 Apr 8. PMID: 33839370.
  36. Friis S, Melle I, Johannessen JO, Røssberg JI, Barder HE, Evensen JH, Haahr U, Ten Velden Hegelstad W, Joa I, Langeveld J, Larsen TK, Opjordsmoen S, Rund BR, Simonsen E, Vaglum PW, McGlashan TH. Early Predictors of Ten-Year Course in First-Episode Psychosis. Psychiatr Serv. 2016 Apr 1;67(4):438-43. https//doi.org/10.1176/appi.ps.201400558. Epub 2015 Nov 16. PMID: 26567932.
  37. Puig O, Baeza I, de la Serna E, Cabrera B, Mezquida G, Bioque M, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, Bobes J, Usall J, Contreras F, Cuesta MJ, Bernardo M, Castro-Fornieles J; PEPs Group. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset. J Clin Psychiatry. 2017 Nov/Dec;78(9):1414-1422. https//doi.org/10.4088/JCP.16m11122. PMID: 28922588.
  38. Gupta T, Cowan HR, Strauss GP, Walker EF, Mittal VA. Deconstructing negative symptoms in individuals at clinical high-risk for psychosis: Evidence for volitional and diminished emotionality subgroups that predict clinical presentation and functional outcome. Schizophr Bull. 2021 Jan 23;47(1):54-63. https//doi.org/10.1093/schbul/sbaa084. PMID: 32955097; PMCID: PMC7825091.
  39. Petrova NN. The problem of “recovery” in schizophrenia. Social and Clinical Psychiatry. 2023;33(3):81-87 (in Russian).